Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
What's behind PEPFAR's funding cut threats?

As it wraps up its latest funding round, the President's Emergency Plan for AIDS Relief is prepared to introduce unprecedented cuts to country programs in sub-Saharan Africa, designed to spur domestic policy changes and programmatic improvements. But observers warn that if enacted, the cuts could undermine advances those countries have made against the HIV epidemic, particularly among marginalized communities that struggle to access health services.

Published
12 June 2019
From
Devex
Which HIV Prevention Methods Are Most Cost Effective in Sub-Saharan Africa?

Researchers conducted a systematic review of 60 studies in search of answers.

Published
11 June 2019
From
POZ
Is Off-Label HIV Prevention Better Than None?

Rather than prescribe F/TDF as PrEP, Michael Saag, MD said, prescribers should sidestep the brand-name product and instead give their PrEP-eligible patients a generic HIV drug combination that uses lamivudine (3TC) with TDF.

Published
31 May 2019
From
MedPage Today (requires free registration)
India: Investing in ART to treat HIV/AIDS

A new analysis has established that further investment in preventing the spread of HIV/AIDS through ART is one of the 12 best investments that India can make to speed up its achievement of the Sustainable Development Goals.

Published
27 May 2019
From
Deccan Herald
Analysis reveals extent of drug industry funding of UK patient organisations

The researchers call for greater transparency to ensure that industry funding is not unduly influenced by commercial objectives.

Published
23 May 2019
From
The BMJ press release
High prevalence of stockouts of antiretroviral medicines in South Africa

One in five public health facilities in South Africa were unable to supply at least one antiretroviral (ARV) or tuberculosis (TB) drug on the day they were contacted

Published
23 May 2019
By
Alain Volny-Anne
The lipstick that has raised $500m for charity

Viva Glam was a Mac counter mainstay that set it apart from other big brands. The first Viva Glam lipstick launched in 1994 at the height of the HIV/Aids epidemic, with the drag queen RuPaul as its face. Decades before cause marketing became a form of reputational currency for beauty brands, Mac was quietly donating 100 per cent of the retail price – less VAT – of Viva Glam products to HIV/Aids causes globally.

Published
21 May 2019
From
Irish Times
Trump Administration Caves To Pharma On Medicare Part D 'Protected Classes' Reform

The Trump administration has shelved a proposal that would have stymied egregious price hikes in the Medicare prescription drug program. It’s a major win for the drug industry, and a defeat for Trump’s goal of reducing drug prices.

Published
17 May 2019
From
Forbes
Vienna Life Ball to raise money for HIV/Aids charities to end

Organisers say it is hard to find sponsors for the event because of progress in tackling the virus.

Published
17 May 2019
From
BBC News
England: Sexual Health Checks Fall By Almost 250,000 As Services Suffer Severe Cuts

Sexual and reproductive health checks have fallen by 245,000 in three years, amid “swingeing” cuts to the vital services, new figures published by the Labour party show. Spending on the facilities by local authorities fell by £56 million over the past five years, according to House of Commons library data.

Published
14 May 2019
From
Huffington Post

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.